These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10415099)

  • 1. Preparation of insoluble transmembrane peptides: glycophorin-A, prion (110-137), and FGFR (368-397).
    Glover KJ; Martini PM; Vold RR; Komives EA
    Anal Biochem; 1999 Aug; 272(2):270-4. PubMed ID: 10415099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable isotope-labeled peptides in study of protein aggregation.
    Baldwin MA
    Methods Enzymol; 1999; 309():576-91. PubMed ID: 10507049
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanoengineered analytical immobilized metal affinity chromatography stationary phase by atom transfer radical polymerization: separation of synthetic prion peptides.
    McCarthy P; Chattopadhyay M; Millhauser GL; Tsarevsky NV; Bombalski L; Matyjaszewski K; Shimmin D; Avdalovic N; Pohl C
    Anal Biochem; 2007 Jul; 366(1):1-8. PubMed ID: 17481564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the human prion protein PrP106-126 with metal complexes: potential therapeutic agents against prion disease.
    Wang Y; Xu J; Wang L; Zhang B; Du W
    Chemistry; 2010 Dec; 16(45):13339-42. PubMed ID: 21031373
    [No Abstract]   [Full Text] [Related]  

  • 5. Reliable expression and purification of highly insoluble transmembrane domains.
    Diefenderfer C; Lee J; Mlyanarski S; Guo Y; Glover KJ
    Anal Biochem; 2009 Jan; 384(2):274-8. PubMed ID: 18929529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
    Peng WC; Lin X; Torres J
    Protein Sci; 2009 Feb; 18(2):450-9. PubMed ID: 19165726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative syntheses of peptides and peptide thioesters derived from mouse and human prion proteins.
    Sebestík J; Zawada Z; Safařík M; Hlaváček J
    Amino Acids; 2012 Sep; 43(3):1297-309. PubMed ID: 22212592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Fmoc-based solid-phase synthesis of homologous peptide fragments of human and mouse prion proteins.
    Grillo-Bosch D; Rabanal F; Giralt E
    J Pept Sci; 2011 Jan; 17(1):32-8. PubMed ID: 20853306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the synthesis and purification of transmembrane peptide fragments. Rat bradykinin receptor fragment 64-97 as model.
    Oliveira E; Miranda A; Albericio F; Andreu D; Paiva AC; Nakaie CR; Tominaga M
    J Pept Res; 1997 Apr; 49(4):300-7. PubMed ID: 9176813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides mimic the assembly of transmembrane glycoproteins.
    Bormann BJ; Knowles WJ; Marchesi VT
    J Biol Chem; 1989 Mar; 264(7):4033-7. PubMed ID: 2783929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
    Boshuizen RS; Langeveld JP; Salmona M; Williams A; Meloen RH; Langedijk JP
    Anal Biochem; 2004 Oct; 333(2):372-80. PubMed ID: 15450815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid sequence of an alpha-delta-glycophorin hybrid. A structure reciprocal to Sta delta-alpha-glycophorin hybrid.
    Johe KK; Smith AJ; Vengelen-Tyler V; Blumenfeld OO
    J Biol Chem; 1989 Oct; 264(29):17486-93. PubMed ID: 2793868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the prion protein using chemical synthesis.
    Ball HL; King DS; Cohen FE; Prusiner SB; Baldwin MA
    J Pept Res; 2001 Nov; 58(5):357-74. PubMed ID: 11892845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic purification of extremely hydrophobic peptides: transmembrane segments.
    Bollhagen R; Schmiedberger M; Grell E
    J Chromatogr A; 1995 Sep; 711(1):181-6. PubMed ID: 7496489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids and peptides. LV. Application of 2-adamantyl derivatives as protecting groups to the synthesis of peptide fragments related to Sulfolobus solifataricus ribonuclease. II.
    Tsuda Y; Joshi S; Shintomi N; Kondo Y; Ohgi K; Irie M; Okada Y
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1097-101. PubMed ID: 10478465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric analysis of prion proteins.
    Baldwin MA
    Adv Protein Chem; 2001; 57():29-54. PubMed ID: 11447694
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantification of structural alterations of L-Asp and L-Asn residues in peptides related to neuronal diseases by reversed-phase high-performance liquid chromatography.
    Sadakane Y; Konoha K; Kawahara M; Nakagomi K
    Chem Biodivers; 2010 Jun; 7(6):1371-9. PubMed ID: 20564556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin prevents aggregation of neuropeptide 106-126 in vitro.
    McHattie S; Edington N
    Biochem Biophys Res Commun; 1999 Jun; 259(2):336-40. PubMed ID: 10362509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated chemical synthesis of peptides and small proteins.
    Miranda LP; Alewood PF
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1181-6. PubMed ID: 9989998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase synthesis of MEN 11270, a new cyclic peptide kinin B2 receptor antagonist.
    Anichini B; Ricci R; Fabbri G; Balacco G; Mauro S; Triolo A; Altamura M; Maggi CA; Quartara L
    J Pept Sci; 2000 Dec; 6(12):612-20. PubMed ID: 11192241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.